Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients

A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 ·Status: COMPLETED ·Phase: PHASE3

D2E7-Early AS

NCT00235105 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)

NCT02985983 ·Status: COMPLETED ·Phase: PHASE3

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

NCT00085644 ·Status: COMPLETED ·Phase: PHASE3

Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

NCT01079182 ·Status: COMPLETED

A Clinical Study to Evaluate the Efficacy of Biologics in SpA

NCT04399382 ·Status: UNKNOWN

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

NCT01754727 ·Status: COMPLETED

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

NCT00265083 ·Status: COMPLETED ·Phase: PHASE3

Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

NCT01064856 ·Status: COMPLETED ·Phase: PHASE3

A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis

NCT00667355 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice

NCT01077258 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis

NCT04481139 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

NCT00235833 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

NCT00233558 ·Status: TERMINATED ·Phase: PHASE4

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)

NCT02349451 ·Status: COMPLETED ·Phase: PHASE2

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

NCT02159053 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

NCT00478660 ·Status: COMPLETED ·Phase: PHASE3

Study of the Human Anti-TNF Monoclonal Antibody in Patients With Active Rheumatoid Arthritis

NCT00649545 ·Status: APPROVED_FOR_MARKETING

Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 Study

NCT02433340 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Influencing Factors of Secukinumab in Patients With Axial Spondyloarthritis

NCT07130331 ·Status: COMPLETED

Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

NCT01114880 ·Status: COMPLETED ·Phase: PHASE3

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

NCT02757352 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Clinical Effectiveness and Safety of Adalimumab and High Dose Methotrexate in Routine Clinical Practice

NCT01736189 ·Status: COMPLETED

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis

NCT02634541 ·Status: UNKNOWN ·Phase: PHASE4

ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis

NCT04795141 ·Status: TERMINATED ·Phase: PHASE2